TARO-TOFACITINIB

Identification of Taro-Tofacitinib

No description

Google image searchProduct monograph

Active ingredient

tofacitinib (tofacitinib citrate), 10 MG

DIN: 02511312

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 28-NOV-2022

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AF — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
• L04AF01 — TOFACITINIB (ATC/DDD)

External Links for Taro-Tofacitinib

Search on Google

• Taro-Tofacitinib side effects
• Taro-Tofacitinib dosage
• tofacitinib side effects
• tofacitinib dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-tofacitinib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.